Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2338288rdf:typepubmed:Citationlld:pubmed
pubmed-article:2338288lifeskim:mentionsumls-concept:C0008972lld:lifeskim
pubmed-article:2338288lifeskim:mentionsumls-concept:C0349633lld:lifeskim
pubmed-article:2338288lifeskim:mentionsumls-concept:C0205470lld:lifeskim
pubmed-article:2338288lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:2338288pubmed:issue1lld:pubmed
pubmed-article:2338288pubmed:dateCreated1990-6-21lld:pubmed
pubmed-article:2338288pubmed:abstractTextHairy cell leukemia (HCL), a well-recognized chronic lymphoproliferative disorder, is frequently characterized by pancytopenia, monocytopenia, splenomegaly and marrow fibrosis, which typically leads to an unsuccessful bone marrow aspiration (dry tap). Patients with a high white cell count without neutropenia and/or monocytopenia, with an aspirable and hypercellular marrow, splenomegaly and neoplastic cells with hairy cell features have been recently recognized and classified as HCL variants. We report here the clinical, hematological and immunological features of 7 such cases. All patients presented splenomegaly with a high leukocyte count; 2 were anemic and only 1 thrombocytopenic. Five patients were treated with alpha-Interferon (alpha-IFN) but 4 failed to achieve any significant response; two of these were subsequently splenectomized and successfully treated with Chlorambucil. Splenectomy, followed by Chlorambucil, was performed at diagnosis in the remaining 2 cases, both of which achieved a partial response and are alive and well. Six out of the 7 patients are still alive. The recognition of these peculiar patients is also important because they most often do not respond to alpha-IFN, while splenectomy, followed by Chlorambucil, may be a reasonable therapeutic option for them.lld:pubmed
pubmed-article:2338288pubmed:languageenglld:pubmed
pubmed-article:2338288pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2338288pubmed:citationSubsetIMlld:pubmed
pubmed-article:2338288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2338288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2338288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2338288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2338288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2338288pubmed:statusMEDLINElld:pubmed
pubmed-article:2338288pubmed:issn0390-6078lld:pubmed
pubmed-article:2338288pubmed:authorpubmed-author:TuraSSlld:pubmed
pubmed-article:2338288pubmed:authorpubmed-author:LauriaFFlld:pubmed
pubmed-article:2338288pubmed:authorpubmed-author:GugliottaLLlld:pubmed
pubmed-article:2338288pubmed:authorpubmed-author:AlgeriRRlld:pubmed
pubmed-article:2338288pubmed:authorpubmed-author:BuzziMMlld:pubmed
pubmed-article:2338288pubmed:authorpubmed-author:BocchiaMMlld:pubmed
pubmed-article:2338288pubmed:authorpubmed-author:ZinzaniP LPLlld:pubmed
pubmed-article:2338288pubmed:authorpubmed-author:RaspadoriDDlld:pubmed
pubmed-article:2338288pubmed:authorpubmed-author:MacchiSSlld:pubmed
pubmed-article:2338288pubmed:issnTypePrintlld:pubmed
pubmed-article:2338288pubmed:volume75lld:pubmed
pubmed-article:2338288pubmed:ownerNLMlld:pubmed
pubmed-article:2338288pubmed:authorsCompleteYlld:pubmed
pubmed-article:2338288pubmed:pagination54-7lld:pubmed
pubmed-article:2338288pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:meshHeadingpubmed-meshheading:2338288-...lld:pubmed
pubmed-article:2338288pubmed:articleTitleHairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 cases.lld:pubmed
pubmed-article:2338288pubmed:affiliationIstituto di Ematologia L. e A. Seràgnoli Università, Bologna, Italy.lld:pubmed
pubmed-article:2338288pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2338288pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2338288pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed